Leka, Kristi ; Université de Liège - ULiège > Unités de recherche interfacultaires > Centre Interdisciplinaire de Recherche sur le Médicament (CIRM)
Mamede, Lucia; University of Liège Faculty of Medicine, Laboratory of Pharmacognosy, CIRM, Building B36 Quartier Hôpital, 4000 Liege, Belgium
Lesenfants, Cindy ; Université de Liège - ULiège > Département de pharmacie > Chimie pharmaceutique
Robbiano, Sofia; University of Liège Laboratory of Veterinary Pathology, FARAH CIRM INDEEP, Building B43a Avenue de Cureghem 6, 4000 Liege, Belgium
Vandeberg, Elyn ; Université de Liège - ULiège > Unités de recherche interfacultaires > Centre Interdisciplinaire de Recherche sur le Médicament (CIRM)
Hamann, Carla ; Université de Liège - ULiège > Unités de recherche interfacultaires > Centre Interdisciplinaire de Recherche sur le Médicament (CIRM)
Frederich, Michel ; Université de Liège - ULiège > Département de pharmacie > Pharmacognosie
Garigliany, Mutien-Marie ✱; Université de Liège - ULiège > Département de morphologie et pathologie (DMP) > Pathologie générale et autopsies
Ledoux, Allison ✱; Université de Liège - ULiège > Département de pharmacie > Pharmacognosie
✱ These authors have contributed equally to this work.
Language :
English
Title :
Usambarensine from Strychnos usambarensis : Revisiting a Bis-Indole Alkaloid for Antiviral Repositioning
Fonds Léon Fredericq F.R.S.-FNRS - Fonds de la Recherche Scientifique FRIA - Fonds pour la Formation à la Recherche dans l'Industrie et dans l'Agriculture
Tyagi, S. et al. RNA Viruses: A Review on Rapid Adaptation Potential and Globally Emerged Pandemics. Acta sci. microbiol 2023, 6, 57–72, 10.31080/ASMI.2023.06.1285
Kramer, L. D.; Li, J.; Shi, P. Y. West Nile virus. Lancet Neurol. 2007, 6, 171–181, 10.1016/S1474-4422(07)70030-3
Pierson, T. C.; Diamond, M. S. The continued threat of emerging flaviviruses. Nat. Microbiol. 2020, 5, 796–812, 10.1038/s41564-020-0714-0
Lycett, S. J.; Duchatel, F.; Digard, P. A brief history of bird flu. Phil. Trans. Biol. Sci. 2019, 374, 20180257, 10.1098/rstb.2018.0257
Reid, A. H.; Taubenberger, J. K. The origin of the 1918 pandemic influenza virus: A continuing enigma. J. Gen. Virol. 2003, 84, 2285–2292, 10.1099/vir.0.19302-0
Petersen, E. et al. Comparing SARS-CoV-2 with SARS-CoV and influenza pandemics. Lancet Infect. Dis. 2020, 20, e238–e244, 10.1016/S1473-3099(20)30484-9
Liu, J. et al. A comparative overview of COVID-19, MERS and SARS: Review article. Int. J. Surg. 2020, 81, 1–8, 10.1016/j.ijsu.2020.07.032
Coleman, C. M.; Frieman, M. B. Coronaviruses: Important Emerging Human Pathogens. J. Virol. 2014, 88, 5209–5212, 10.1128/JVI.03488-13
Zhu, Z.; Lian, X.; Su, X.; Wu, W.; Marraro, G. A.; Zeng, Y. From SARS and MERS to COVID-19: A brief summary and comparison of severe acute respiratory infections caused by three highly pathogenic human coronaviruses. Respir. Res. 2020, 21, 224, 10.1186/s12931-020-01479-w
World Health Organization (WHO) COVID-19 dashboard. https://data.who.int/dashboards/covid19/deaths?n=c.
Yesudhas, D.; Srivastava, A.; Gromiha, M. M. COVID-19 outbreak: history, mechanism, transmission, structural studies and therapeutics. Infection 2021, 49, 199–213, 10.1007/s15010-020-01516-2
Bchetnia, M.; Girard, C.; Duchaine, C.; Laprise, C. The outbreak of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): A review of the current global status. J. Infect. Public Health 2020, 13, 1601–1610, 10.1016/j.jiph.2020.07.011
Gebreyes, W. A.; Dupouy-Camet, J.; Newport, M. J.; Oliveira, C. J. B.; Schlesinger, L. S.; Saif, Y. M.; Kariuki, S.; Saif, L. J.; Saville, W.; Wittum, T. et al. The Global One Health Paradigm: Challenges and Opportunities for Tackling Infectious Diseases at the Human, Animal, and Environment Interface in Low-Resource Settings. PLoS Neglected Trop. Dis. 2014, 8, e3257 10.1371/journal.pntd.0003257
Ludwig, B.; Kraus, F. B.; Allwinn, R.; Doerr, H. W.; Preiser, W. Viral zoonoses - A threat under control?. Intervirology 2003, 46, 71–78, 10.1159/000069749
Zheng, C. et al. International Journal of Infectious Diseases Real-world effectiveness of COVID-19 vaccines: a literature review and. Int. J. Infect. Dis. 2022, 114, 252–260, 10.1016/j.ijid.2021.11.009
Bhambhani, S.; Kondhare, K. R.; Giri, A. P. Diversity in Chemical Structures and Biological Properties of Plant Alkaloids. Molecules 2021, 26, 3374, 10.3390/molecules26113374
Heinrich, M.; Mah, J.; Amirkia, V. Alkaloids Used as Medicines: Structural Phytochemistry Meets Biodiversity An Update and Forward Look. Molecules 2021, 26, 1836, 10.3390/molecules26071836
Abookleesh, F. L.; Al-Anzi, B. S.; Ullah, A. Potential Antiviral Action of Alkaloids. Molecules 2022, 27, 903, 10.3390/molecules27030903
Leka, K.; Mamede, L.; Vandeberg, E.; Garigliany, M. Natural Alkaloids as Antiviral Agents Against RNA Viruses: A Comprehensive and Mechanistic Review. Molecules 2026, 33, 539, 10.3390/molecules31030539
Kim, D. E.; Min, J.; Jang, M.; Lee, J.; Shin, Y.; Park, C.; Song, J.; Kim, H.; Kim, S.; Jin, Y. H. et al. Natural bis-benzylisoquinoline alkaloids-tetrandrine, fangchinoline, and cepharanthine, inhibit human coronavirus oc43 infection of mrc-5 human lung cells. Biomolecules 2019, 9, 696, 10.3390/biom9110696
Bechlem, H.; Benayache, F.; Benouchenne, D.; Labed, A. DNA intercalators alkaloids as Potential candidates to fight COVID-19 disease: Systematic review. J. Res. Pharm. 2022, 26 (5), 1102–1111, 10.29228/jrp.206
Wei, J.; Liu, S.; Bian, Y.; Li, L.; Qian, B.; Shen, Z.; Zhang, Y.; Abuduaini, A.; Dong, F.; Zhang, X. et al. Safety and efficacy of oral administrated cepharanthine in non-hospitalized, asymptomatic or mild COVID-19 patients: a Double-blind, randomized, placebo-controlled trial: Author detials. Sci. Rep. 2025, 15, 3875, 10.1038/s41598-024-75891-3
Cao, M.; Muganga, R.; Tits, M.; Angenot, L.; Frédérich, M. 17-O-acetyl,10-hydroxycorynantheol, a selective antiplasmodial alkaloid isolated from strychnos usambarensis leaves. Planta Med. 2011, 77, 2050–2053, 10.1055/s-0031-1280124
Philippe, G.; Angenot, L. Recent developments in the field of arrow and dart poisons. J. Ethnopharmacol. 2005, 100, 85–91, 10.1016/j.jep.2005.05.022
Angenot, L.; Dubois, M.; Ginion, C.; van Dorsser, W.; Dresse, A. Chemical structure and pharmacological (curarizing) properties of various indole alkaloids extracted from an African Strychnos. Arch. Int. Pharmacodyn. Ther. 1975, 215, 246–258
Angenot, L.; Dubois, M.; Ginion, C.; van Dorsser, W.; Dresse, A. Chemical structure and pharmacological (curarizing) properties of various indole alkaloids extracted from an African Strychnos. Arch Int Pharmacodyn Ther. 1975, 215 (2), 246–258PMID: 126050.
Angenot, L. Why further investigation of brazilian Strychnos?. Acta Amazonica 1988, 18, 241–254, 10.1590/1809-43921988185254
Wright, C. W. et al. Antiamoebic and antiplasmodial activities of alkaloids isolated from Strychnos usambarensis. Planta Med. 1991, 57, 337–340, 10.1055/s-2006-960112
Ledoux, A. et al. In vitro antiviral activity against SARS-CoV-2 of 28 Strychnos extracts. Phytother. Res. 2022, 36, 1061–1063, 10.1002/ptr.7394
Misset, B.; Hoste, E.; Donneau, A. F.; Grimaldi, D.; Meyfroidt, G.; Moutschen, M.; Compernolle, V.; Gothot, A.; Desmecht, D.; Garigliany, M. et al. A multicenter randomized trial to assess the efficacy of CONvalescent plasma therapy in patients with Invasive COVID-19 and acute respiratory failure treated with mechanical ventilation: the CONFIDENT trial protocol. BMC Pulm. Med. 2020, 20, 317–319, 10.1186/s12890-020-01361-x
Lu, X. et al. US CDC real-time reverse transcription PCR panel for detection of severe acute respiratory syndrome Coronavirus 2. Emerg. Infect. Dis. 2020, 26, 1654–1665, 10.3201/eid2608.201246
Yu, B.; Xu, C.; Huang, S.; Ni, J.; Zhou, J.; Zhang, Y.; Wu, M.; Zhang, J.; Fang, L. Development of a universal real-time RT-PCR assay for detection of pan-SARS-coronaviruses with an RNA-based internal control. Front. Microbiol. 2023, 14, 1181097, 10.3389/fmicb.2023.1181097
Corman, V. M.; Eckerle, I.; Bleicker, T.; Zaki, A.; Landt, O.; Eschbach-Bludau, M.; van Boheemen, S.; Gopal, R.; Ballhause, M.; Bestebroer, T. M. et al. Detection of a novel human coronavirus by real-time reverse-transcription polymerase chain reaction. Eurosurveillance 2012, 17, 1, 10.2807/ese.17.39.20285-en
Vries, E. V. D. et al. Molecular Assays for Quantitative and Qualitative Detection of In fl uenza Virus and Oseltamivir Resistance Mutations. J. Mol. Diagn. 2013, 15, 347–354, 10.1016/j.jmoldx.2012.11.007
Steven, E. OIE Terrestrial Manual 2018; World Organisation for Animal Health2018.
Piorkowski, G. et al. Development of generic Taqman PCR and RT-PCR assays for the detection of DNA and mRNA of β-actin-encoding sequences in a wide range of animal species. J. Virol. Methods 2014, 202, 101–105, 10.1016/j.jviromet.2014.02.026
Hoste, A. C. R.; Smeralda, W.; Cugnet, A.; Brostaux, Y.; Deleu, M.; Garigliany, M.; Jacques, P. The structure of lipopeptides impacts their antiviral activity and mode of action against SARS-CoV-2 in vitro. Appl. Environ. Microbiol. 2024, 90, e01036-24 10.1128/aem.01036-24
Reed, L. J.; Muench, H. A simple method of estimating fifty percent endpoint. Am. J. Hyg. 1938, 27, 493–497, 10.1093/oxfordjournals.aje.a118408
Claude, A.C.; Luc, J.G. A.; José, D.13C NMR of Strychnos Alkaloids: Harmane and Usambarensine Derivatives. Phytochemistry 2009, 19, 2009–2011, 10.1016/0031-9422(80)83024-X
Grigoriev, D. A.; Semenov, V. A.; Angenot, L.; Krivdin, L. B. Configurational and Conformational Studies of Quinolizidine and Beta-Carboline Moieties in the Corynanthe-Tryptamine Alkaloids. Int. J. Quantum Chem. 2025, 125, e70008–e70011, 10.1002/qua.70008
Dassonneville, L. et al. The plant alkaloid usambarensine intercalates into DNA and induces apoptosis in human HL60 leukemia cells. Anticancer Res. 1999, 19, 5245–5250
Bonjean, K. A. P. M.; De Pauw-Gillet, M. C. A. J.; Quetin-Leclercq, J.; Angenot, L.; Bassleer, R. J. B. In vitro cytotoxic activity of two potential anticancer drugs isolated from Strychnos: Strychnopentamine and usambarensine. Anticancer Res. 1996, 16, 1129–1137
Letko, M.; Marzi, A.; Munster, V. Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses. Nat. Microbiol. 2020, 5, 562–569, 10.1038/s41564-020-0688-y
Wang, N. et al. Structure of MERS-CoV spike receptor-binding domain complexed with human receptor DPP4. Cell Res. 2013, 23, 986–993, 10.1038/cr.2013.92
Magrone, T.; Magrone, M.; Jirillo, E. Focus on Receptors for Coronaviruses with Special Reference to Angiotensin- Converting Enzyme 2 as a Potential Drug Target - A Perspective. Endocr. Metab. Immune Disord.:Drug Targets 2020, 20, 807–811, 10.2174/1871530320666200427112902
Mori, Y.; Yamashita, T.; Tanaka, Y.; Tsuda, Y.; Abe, T.; Moriishi, K.; Matsuura, Y. Processing of Capsid Protein by Cathepsin L Plays a Crucial Role in Replication of Japanese Encephalitis Virus in Neural and Macrophage Cells. J. Virol. 2007, 81, 8477–8487, 10.1128/jvi.00477-07
Chu, J. J. H.; Ng, M. L. Infectious Entry of West Nile Virus Occurs through a Clathrin-Mediated Endocytic Pathway. J. Virol. 2004, 78, 10543–10555, 10.1128/JVI.78.19.10543-10555.2004
Sieben, C.; Sezgin, E.; Eggeling, C.; Manley, S. Influenza a viruses use multivalent sialic acid clusters for cell binding and receptor activation. PLoS Pathog. 2020, 16, e1008656 10.1371/journal.ppat.1008656
Xia, B.; Zheng, L.; Li, Y.; Sun, W.; Liu, Y.; Li, L.; Pang, J.; Chen, J.; Li, J.; Cheng, H. The brief overview, antivirus and anti-SARS-CoV-2 activity, quantitative methods, and pharmacokinetics of cepharanthine: a potential small-molecule drug against COVID-19. Front. Pharmacol. 2023, 14, 1098972, 10.3389/fphar.2023.1098972
Leng, L.; Xu, Z.; Hong, B.; Zhao, B.; Tian, Y.; Wang, C.; Yang, L.; Zou, Z.; Li, L.; Liu, K. et al. Cepharanthine analogs mining and genomes of Stephania accelerate anti-coronavirus drug discovery. Nat. Commun. 2024, 15, 1537, 10.1038/s41467-024-45690-5
Liu, J.; Wang, F.; Wang, X.; Fan, S.; Li, Y.; Xu, M.; Hu, H.; Liu, K.; Zheng, B.; Wang, L. et al. Antiviral effects and tissue exposure of tetrandrine against SARS-CoV-2 infection and COVID-19. MedComm 2023, 4, e206–e216, 10.1002/mco2.206
Ogunyemi, O. M.; Gyebi, G. A.; Elfiky, A. A.; Afolabi, S. O.; Ogunro, O. B.; Adegunloye, A. P.; Ibrahim, I. M. Alkaloids and flavonoids from African phytochemicals as potential inhibitors of SARS-Cov-2 RNA-dependent RNA polymerase: an in silico perspective. Antivir. Chem. Chemother. 2020, 28, 204020662098407, 10.1177/2040206620984076
Diederich, S. et al. Activation of the Nipah Virus Fusion Protein in MDCK Cells Is Mediated by Cathepsin B within the Endosome-Recycling Compartment. J. Virol. 2012, 86, 3736–3745, 10.1128/JVI.06628-11
Chandran, K.; Sullivan, N. J.; Felbor, U.; Whelan, S. P.; Cunningham, J. M. Virology: Endosomal proteolysis of the ebola virus glycoprotein is necessary for infection. Science 2005, 308, 1643–1645, 10.1126/science.1110656
Sanchez, A. Analysis of filovirus entry into Vero E6 cells, using inhibitors of endocytosis, endosomal acidification, structural integrity, and cathepsin (B and L) activity. J. Infect. Dis. 2007, 196, 251–258, 10.1086/520597
Pager, C. T.; Dutch, R. E. Cathepsin L Is Involved in Proteolytic Processing of the Hendra Virus Fusion Protein. J. Virol. 2005, 79, 12714–12720, 10.1128/JVI.79.20.12714-12720.2005
Starr, T. N. et al. Prospective mapping of viral mutations that escape antibodies used to treat COVID-19. Science 2021, 371, 850–854, 10.1126/science.abf9302
van Egeren, D.; Novokhodko, A.; Stoddard, M.; Tran, U.; Zetter, B.; Rogers, M.; Pentelute, B. L.; Carlson, J. M.; Hixon, M.; Joseph-McCarthy, D. et al. Risk of rapid evolutionary escape from biomedical interventions targeting SARS-CoV-2 spike protein. PLoS One 2021, 16, e0250780 10.1371/journal.pone.0250780
Breining, P. et al. Camostat mesylate against SARS-CoV-2 and COVID-19 Rationale, dosing and safety. Basic Clin. Pharmacol. Toxicol. 2021, 128, 204–212, 10.1111/bcpt.13533
Zhou, Y. et al. Protease inhibitors targeting coronavirus and filovirus entry. Antiviral Res. 2015, 116, 76–84, 10.1016/j.antiviral.2015.01.011
Aiewsakun, P.; Phumiphanjarphak, W.; Ludowyke, N.; Purwono, P. B.; Manopwisedjaroen, S.; Srisaowakarn, C.; Ekronarongchai, S.; Suksatu, A.; Yuvaniyama, J.; Thitithanyanont, A. Systematic Exploration of SARS-CoV-2 Adaptation to Vero E6, Vero E6/TMPRSS2, and Calu-3 Cells. Genome Biol. Evol. 2023, 15, evad035 10.1093/gbe/evad035
Flury, P. et al. Cathepsin-Targeting SARS-CoV-2 Inhibitors: Design, Synthesis, and Biological Activity. ACS Pharmacol. Transl. Sci. 2024, 7, 493–514, 10.1021/acsptsci.3c00313
